Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 6
2022 7
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics of subjective cognitive decline associated with amyloid positivity.
Janssen O, Jansen WJ, Vos SJB, Boada M, Parnetti L, Gabryelewicz T, Fladby T, Molinuevo JL, Villeneuve S, Hort J, Epelbaum S, Lleó A, Engelborghs S, van der Flier WM, Landau S, Popp J, Wallin A, Scheltens P, Rikkert MO, Snyder PJ, Rowe C, Chételat G, Ruíz A, Marquié M, Chipi E, Wolfsgruber S, Heneka M, Boecker H, Peters O, Jarholm J, Rami L, Tort-Merino A, Binette AP, Poirier J, Rosa-Neto P, Cerman J, Dubois B, Teichmann M, Alcolea D, Fortea J, Sánchez-Saudinós MB, Ebenau J, Pocnet C, Eckerström M, Thompson L, Villemagne V, Buckley R, Burnham S, Delarue M, Freund-Levi Y, Wallin ÅK, Ramakers I, Tsolaki M, Soininen H, Hampel H, Spiru L; Alzheimer's Disease Neuroimaging Initiative; FACEHBI study group; PREVENT-AD research group; Tijms B, Ossenkoppele R, Verhey FRJ, Jessen F, Visser PJ. Janssen O, et al. Among authors: ebenau j. Alzheimers Dement. 2022 Oct;18(10):1832-1845. doi: 10.1002/alz.12512. Epub 2021 Dec 8. Alzheimers Dement. 2022. PMID: 34877782 Free PMC article.
Longitudinal change in ATN biomarkers in cognitively normal individuals.
Ebenau JL, Visser D, Kroeze LA, van Leeuwenstijn MSSA, van Harten AC, Windhorst AD, Golla SVS, Boellaard R, Scheltens P, Barkhof F, van Berckel BNM, van der Flier WM. Ebenau JL, et al. Alzheimers Res Ther. 2022 Sep 3;14(1):124. doi: 10.1186/s13195-022-01069-6. Alzheimers Res Ther. 2022. PMID: 36057616 Free PMC article.
Subjective cognitive decline and self-reported sleep problems: The SCIENCe project.
Exalto LG, Hendriksen HMA, Barkhof F, van den Bosch KA, Ebenau JL, van Leeuwenstijn-Koopman M, Prins ND, Teunissen CE, Visser LNC, Scheltens P, van der Flier WM. Exalto LG, et al. Among authors: ebenau jl. Alzheimers Dement (Amst). 2022 May 15;14(1):e12287. doi: 10.1002/dad2.12287. eCollection 2022. Alzheimers Dement (Amst). 2022. PMID: 35603141 Free PMC article.
Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial.
Fruijtier AD, van der Schaar J, van Maurik IS, Zwan MD, Scheltens P, Bouwman F, Pijnenburg YAL, van Berckel BNM, Ebenau J, van der Flier WM, Smets EMA, Visser LNC. Fruijtier AD, et al. Among authors: ebenau j. Alzheimers Dement. 2023 Jan;19(1):285-295. doi: 10.1002/alz.12630. Epub 2022 Apr 2. Alzheimers Dement. 2023. PMID: 35366050 Free PMC article. Clinical Trial.
Grey zone amyloid burden affects memory function: the SCIENCe project.
Ebenau JL, Verfaillie SCJ, van den Bosch KA, Timmers T, Wesselman LMP, van Leeuwenstijn M, Tuncel H, Golla SVS, Yaqub MM, Windhorst AD, Prins ND, Barkhof F, Scheltens P, van der Flier WM, van Berckel BNM. Ebenau JL, et al. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):747-756. doi: 10.1007/s00259-020-05012-5. Epub 2020 Sep 4. Eur J Nucl Med Mol Imaging. 2021. PMID: 32888039 Free PMC article.
Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals.
Ebenau JL, Visser D, Verfaillie SCJ, Timmers T, van Leeuwenstijn MSSA, Kate MT, Windhorst AD, Barkhof F, Scheltens P, Prins ND, Boellaard R, van der Flier WM, van Berckel BNM. Ebenau JL, et al. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):410-422. doi: 10.1007/s00259-022-05958-8. Epub 2022 Sep 8. Eur J Nucl Med Mol Imaging. 2023. PMID: 36071221 Free PMC article.
ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project.
Ebenau JL, Timmers T, Wesselman LMP, Verberk IMW, Verfaillie SCJ, Slot RER, van Harten AC, Teunissen CE, Barkhof F, van den Bosch KA, van Leeuwenstijn M, Tomassen J, Braber AD, Visser PJ, Prins ND, Sikkes SAM, Scheltens P, van Berckel BNM, van der Flier WM. Ebenau JL, et al. Neurology. 2020 Jul 7;95(1):e46-e58. doi: 10.1212/WNL.0000000000009724. Epub 2020 Jun 10. Neurology. 2020. PMID: 32522798 Free PMC article.
Changes in self- and study partner-perceived cognitive functioning in relation to amyloid status and future clinical progression: Findings from the SCIENCe project.
Dubbelman MA, Sikkes SAM, Ebenau JL, van Leeuwenstijn MSSA, Kroeze LA, Trieu C, van Berckel BNM, Teunissen CE, van Harten AC, van der Flier WM. Dubbelman MA, et al. Among authors: ebenau jl. Alzheimers Dement. 2023 Jul;19(7):2933-2942. doi: 10.1002/alz.12931. Epub 2023 Jan 15. Alzheimers Dement. 2023. PMID: 36642977
Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score.
Ebenau JL, van der Lee SJ, Hulsman M, Tesi N, Jansen IE, Verberk IMW, van Leeuwenstijn M, Teunissen CE, Barkhof F, Prins ND, Scheltens P, Holstege H, van Berckel BNM, van der Flier WM. Ebenau JL, et al. Alzheimers Dement (Amst). 2021 Sep 14;13(1):e12229. doi: 10.1002/dad2.12229. eCollection 2021. Alzheimers Dement (Amst). 2021. PMID: 34541285 Free PMC article.
14 results